Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
CV Sciences has settled an arbitration case initiated in February 2025 against its former legal counsel. Under the settlement terms, the company received $500,000 and both parties have mutually released all claims against each other.
Cumberland Pharmaceuticals announced plans to submit a New Drug Application (NDA) for ifetroban to treat cardiomyopathy associated with Duchenne muscular dystrophy (DMD). The submission is supported by Phase 2 FIGHT DMD trial data showing a statistically significant 5.4% improvement in left ventricular ejection fraction (LVEF) compared to a control group. While the FDA expressed concerns regarding the sufficiency of the data package for efficacy requirements, the company is moving forward with the submission following a pre-NDA meeting.
Praetorian Acquisition Corp. implemented a planned leadership transition, appointing Joseph Tonnos as Chief Financial Officer and a director, succeeding Peter Ondishin. The company also appointed Roger L. Cloutier, Jimmy Vaiopoulos, and Charles P. Garcia to its board of directors following the resignations of Nicole Seligman, Erica Dorfman, and Alex Elias.
Bain Capital Private Credit declared a regular monthly distribution of $0.1875 per Class I share for shareholders of record as of October 30, 2026. The filing also disclosed a net asset value (NAV) per share of $26.03 as of September 30, 2026, and the sale of $57.0 million in unregistered shares to feeder vehicles.
Weave Communications Signs $650M M&A Deal with Francisco Partners
Weave Communications, Inc. completed its acquisition by Francisco Partners in an all-cash transaction valued at approximately $650 million. Under the terms of the deal, Weave stockholders received $7.40 per share, and the company has transitioned to a privately held entity, delisting from the New York Stock Exchange.
Value
$650M
Counterparty
Francisco Partners
“Today marks the start of an exciting new chapter for Weave. For nearly two decades, Weave has built solutions for independent practices caring for patients in communities across the country. Today, more than 40,000 locations rely on us to deepen their relationship with patients through automated communication and engagement solutions. With Francisco Partners’ support and resources, we’re well positioned to deliver even more value to the practices we serve. I want to thank our employees, whose dedication made this milestone possible.”
Brett White, Chief Executive Officer of Weave
“Weave sits at the center of how tens of thousands of healthcare practices communicate with their patients and collect revenue. We are pleased to officially partner with Brett and the Weave team and see significant opportunity to build on that position through continued product innovation in AI-powered patient engagement and payments solutions.”
Atlantic Union Bankshares EVP Matthew L. Linderman Sells $310K of Stock
Matthew L. Linderman, EVP, sold 7,746 shares of Atlantic Union Bankshares Corp at $40.00 a share, worth $310K in total on Oct 22, 2026. Shares held after the trade: 10,455 (-42.6%).
FirstSun Capital Bancorp reported Q3 2026 net income of $38.4 million, or $0.82 per diluted share, reflecting improved net interest margins and operating synergies from its recent acquisition of First Foundation. The company also completed a core system conversion for First Foundation and repurchased $49.7 million of its own common stock during the quarter.
Term
Q3 2026
“Third quarter results reflect our continued progress on our strategic priorities highlighted by an improved net interest margin as a result of continued balance sheet improvements, a strong diversified revenue profile and improved earnings performance, including benefits from operating synergies realized following the acquisition of First Foundation in the second quarter.”
Neal Arnold, FirstSun’s Chief Executive Officer and President
“Additionally, in late September, we successfully completed the core system conversion of First Foundation, representing another important milestone in our overall integration plan. I'm extremely proud of our teammates for all the hard work, planning and collaboration in completing the conversion while continuing to serve our great clients throughout the process.”
Neal Arnold, FirstSun’s Chief Executive Officer and President
TrueBlue, Inc. has appointed Elizabeth Castro Gulacsy to its Board of Directors and its Audit Committee, effective October 26, 2026. Ms. Castro Gulacsy, the former CFO of United Parks & Resorts, joins as an independent director as part of a board refreshment process and a previously disclosed cooperation agreement with EHS Management. Her appointment increases the total number of directors on the TrueBlue board to ten.
HPS Corporate Lending Fund declared regular and variable supplemental distributions for October 2026 across all share classes, payable to shareholders of record as of October 31, 2026. The total net distribution for Class I shares is $0.1990 per share, with payments expected on or about November 30, 2026. The Fund also reported a net asset value (NAV) of $24.45 per share for all classes as of September 30, 2026.
NewHydrogen, Inc. entered into a securities purchase agreement with SunHydrogen, Inc. to raise approximately $3 million through the issuance of 203,650,000 shares of common stock and warrants to purchase an additional 407,300,000 shares. The common stock was priced at $0.01473 per share, and the proceeds are intended for general corporate purposes and working capital.
North Haven Private Income Fund A M&A Deal with North Haven Private Income Fund LLC
North Haven Private Income Fund A LLC (PIF A) has entered into a definitive merger agreement to be acquired by North Haven Private Income Fund LLC (PIF). The transaction will be a NAV-for-NAV exchange where PIF A unitholders will receive Class I units of PIF, creating a combined entity with approximately $6.6 billion in total investments.
Counterparty
North Haven Private Income Fund LLC
“we are pleased with the Companies’ performance and believe the Merger will create value for investors, including through a reduced management fee. The Merger advances our long-standing strategic vision and better positions PIF to capitalize on the strength of the Morgan Stanley platform to scale further in the marketplace.”
Michael Occi, Chief Executive Officer of the Companies
D.R. Horton, Inc. appointed Carl E. Reichardt, Jr. to its Board of Directors as an independent director, effective October 22, 2026. Mr. Reichardt will receive an annual cash fee of $80,000, an annual RSU award valued at $235,000, and a one-time new director RSU grant valued at $250,000.
PennantPark Private Income Fund Capital Raise of $3.08M
PennantPark Private Income Fund issued and sold 118,703 common shares for aggregate proceeds of approximately $3.08 million on October 1, 2026. The sale was conducted as part of the company's ongoing continuous private offering to accredited investors. Additionally, the company reported a net asset value (NAV) per share of $25.95 as of September 30, 2026.
Applied Materials Partnership with BE Semiconductor Industries N.V.
Applied Materials entered into an accelerated share purchase agreement to increase its minority stake in BE Semiconductor Industries (Besi) to approximately 20%. The investment reinforces a long-term strategic partnership focused on co-innovating advanced packaging and hybrid bonding technologies for AI-driven semiconductor scaling.
H2O America reported operating revenue of $644.0 million for the nine months ended September 30, 2026, a 6.2% increase over the prior year. Net income for the same period rose to $88.6 million, supported by the recent acquisition of Quadvest's water and wastewater assets, though earnings per share decreased due to a higher weighted average share count.
Health In Tech appointed Sanjay Shrestha as Chief Executive Officer, succeeding founder Tim Johnson who transitioned to Executive Chairman. Mr. Shrestha's employment agreement includes a $500,000 base salary (increasing to $700,000 upon a $10M capital raise), eligibility for a cash bonus up to 200% of salary, and various equity awards.
North Haven Private Income Fund M&A Deal with North Haven Private Income Fund A LLC
North Haven Private Income Fund LLC (PIF) has entered into a definitive agreement to acquire North Haven Private Income Fund A LLC (PIF A) in a NAV-for-NAV exchange ratio merger. The combined entity is expected to have approximately $6.6 billion in total investments at fair value and will benefit from a reduced management fee of 1.00%. The transaction is expected to close in December 2026, subject to regulatory approvals and customary closing conditions.
Counterparty
North Haven Private Income Fund A LLC
“we are pleased with the Companies’ performance and believe the Merger will create value for investors, including through a reduced management fee. The Merger advances our long-standing strategic vision and better positions PIF to capitalize on the strength of the Morgan Stanley platform to scale further in the marketplace.”
Michael Occi, Chief Executive Officer of the Companies
Welltower Inc. reported Q3 2026 net income of $415 million, or $0.54 per diluted share, with normalized FFO increasing 24.6% year-over-year to $1.67 per share. The company achieved significant organic growth with total portfolio same-store NOI up 15.8%, driven by a 21.0% increase in its Seniors Housing Operating portfolio. Welltower also declared its 222nd consecutive quarterly cash dividend of $0.85 per share.
Lazard, Inc. reported net revenue of $814.2 million for the third quarter of 2026, with net income attributable to Lazard of $29.2 million. For the first nine months of 2026, net revenue increased to $2.38 billion compared to $2.19 billion in the prior year, though operating income declined due to higher compensation and benefit expenses.
Dorman Products reported Q3 2026 net sales of $561.7 million, a 3.3% increase year-over-year, though diluted EPS fell 20% to $1.98. The company narrowed its full-year 2026 guidance and highlighted record year-to-date share repurchases totaling $112 million.
Term
Q3 2026
“We delivered solid performance in the quarter. Net sales increased 3%, with top-line growth across each of our three business segments driven by new products and business wins. Diluted EPS was $1.98, and adjusted diluted EPS was $2.08, compared to $2.48 and $2.62, respectively, in the prior-year period. The year-over-year earnings comparison reflects the timing of tariff-related pricing that benefitted the third quarter of 2025. We also generated $65 million of operating cash flow and repurchased $15 million of our common stock in the quarter, bringing year-to-date share repurchases to a company record of $112 million.”
Kevin Olsen, Dorman’s Chairman, President, and Chief Executive Officer
FullPAC Debt Financing Update with Stripe Servicing, Inc. and Lead Bank
FullPAC's subsidiary RoboCent entered into a $250,000 loan agreement with Stripe Servicing and Lead Bank, which includes a $34,250 fixed fee. The proceeds were used to refinance a prior $88,759 Stripe loan and to repay a $300,000 secured promissory note held by SEG Opportunity Fund, LLC.
Globe Life EVP - Chief Strategy Officer Michael Clay Majors Sells $2.22M of Stock
Michael Clay Majors, EVP - Chief Strategy Officer, sold 14,377 shares of Globe Life Inc. at $154.48 a share, worth $2.22M in total on Oct 23, 2026. Shares held after the trade: 39,141 (-26.9%).
UiPath Cpo & CTO Raghavendra Malpani Sells $414K of Stock
Raghavendra Malpani, Cpo & CTO, sold 29,565 shares of UiPath, Inc. at $14.00 a share, worth $414K in total on Oct 22, 2026. Shares held after the trade: 1,484,716 (-2.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.54M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $577.68 to $588.00 a share (average $582.76) in 11 transactions, worth $5.54M in total on Oct 23, 2026. Shares held after the trade: 324,443 (-0.2%).
Northpointe Bancshares announced that its Board of Directors has authorized a new stock repurchase program to buy back up to $30 million of its outstanding common stock. The program is effective from October 22, 2026, through October 22, 2027, and allows for repurchases in the open market or through private transactions.
HPS Corporate Capital Solutions Fund declared regular monthly distributions for October 2026 of $0.1390 per share for all share classes, payable to shareholders of record as of October 31, 2026. The filing also reported a September 30, 2026 NAV of $27.30 per share and disclosed $8.74 million in new share sales from its October 1 subscription date.
Easterly Government Properties reported net income of $5.5 million for the third quarter of 2026, a significant increase from $1.2 million in the prior year, driven by higher rental income. Total assets decreased slightly to $3.37 billion as of September 30, 2026, while the company maintained a steady dividend of $0.45 per share for the quarter.
Fidus Investment $120M Debt Financing with U.S. Bank Trust Company, National Association
Fidus Investment Corporation completed an exchange offer for $120.0 million in aggregate principal amount of its 6.625% Notes due 2029. The company entered into a Seventh Supplemental Indenture to issue registered Exchange Notes in place of previously issued Restricted Notes, satisfying its obligations under a prior registration rights agreement.
OpenWorld, Inc. appointed Gerard Hernandez as Chief Financial Officer, effective October 23, 2026, succeeding Jennifer Cola who was removed from the role. Hernandez previously served as the company's Chief Accounting Officer and is a co-founder of the OpenWorld business.
Marella Thorell, Executive Vice President and Chief Financial Officer of Seres Therapeutics, Inc., resigned from her positions effective November 15, 2026. She is expected to provide advisory services to the company following her departure to support an orderly transition.